Search
Search exact matches first, then pivot into a structured research workspace when direct coverage is thin.
Article matches
Advances in cancer treatment and vaccine efficacy contrast with concerns over AI's impact on public health and a lawsuit against a transgender health group
SpaceX goes public, OpenAI tackles child exploitation, and Probably raises funds for reliable AI
Recent developments in global health, from Ebola and hantavirus outbreaks to FDA leadership changes and public health concerns
Melbourne is set to join other Australian cities in the tap-and-go era, with the state government launching public trials for contactless credit and debit card payments on four train lines: Craigieburn, Upfield, Ballarat,
The US Supreme Court's decision to strike down Donald Trump's tariffs sent shockwaves through the markets, with trade-linked stocks fluctuating wildly. Meanwhile, California is investing heavily in its public transit system, and JPMorgan is leading a major debt deal to support a healthcare software acquisition.
Illinois Governor JB Pritzker has proposed a two-year moratorium on tax incentives for data centers, citing growing public pushback against the resource-hungry facilities. The move reflects increasing concerns over the environmental and economic impacts of data centers. If approved by state lawmakers, the proposal could have significant implications for the tech industry.
As the US struggles with the high cost of public transit, China's president Xi Jinping touts the country's massive market as a key driver of economic growth. Meanwhile, experts argue that smarter procurement and increased competition could help American cities get more buses for less money.
President Trump is facing criticism from within his own party after posting a racist video on social media, while former President Bill Clinton is calling for a public hearing on his testimony regarding convicted sex offender Jeffrey Epstein. The EPA has also reapproved the use of the herbicide dicamba with some restrictions.
Ethos Technologies made its public debut on the stock market on [date] after raising approximately $200 million in an initial public offering (IPO) The company's shares saw a drop in trading following the debut. Ethos' CEO, Peter Colis, spoke with Bloomberg about the company's innovative life insurance platform.
US public pensions could pay out almost 90% of promised benefits over next six months. However, risks are also climbing, as investors consider the implications of large share sales in the private markets.
Merger arbitrage investors are optimistic about dealmaking in the first quarter. Biotech firms are currently at the top of the list for potential takeover candidates. Brazil's next government faces the challenge of presenting a credible fiscal plan to stabilize public debt. Baker Hughes reported earnings that beat expectations in a sluggish energy market.
A growing trend of secrecy and cover-ups in environmental and energy issues raises concerns about transparency and accountability.
The past week has seen significant developments in the healthcare sector, with the Covid vaccine rollout being praised as an "extraordinary feat" and new cancer treatments offering hope for patients.
In recent weeks, several groundbreaking studies have made headlines, highlighting significant advancements in various fields.
Amid rising tensions, US Vice-President JD Vance claims a peace deal with Iran is near, while the UK and allies impose sanctions on networks enabling settler violence in the West Bank.
Cybersecurity Landscape Shifts as AI Models Roll Out and Threats Evolve Rise of Powerful AI and Humanoid Robots Sparks Concerns The increasing availability of advanced AI models and humanoid robots is transforming the cybersecurity
From Big Tobacco's influence on food to Elmo's sportsmanship tweet, companies face scrutiny
Exploring the World of PR, Acting, and the Power of Storytelling
Ebola Outbreak Declared International Emergency, New Cancer Test Brings Hope, and Women's Health Issues Highlighted
Vaccine policies, outbreaks, and pharma trade deals spark debate and action